@conference{31e2cfab456d40ebb45f793aa114c7c3,
title = "Impact of EGFR and ALK mutation on the outcomes of non-small cell lung cancer (NSCLC) patients with brain metastases.",
author = "Balasubramanian, {Suresh Kumar} and Venur, {Vyshak Alva} and Chao, {Samuel T.} and Lilyana Angelov and Mohammadi, {Alireza Mohammad} and Barnett, {Gene H.} and Xuefei Jia and Ahluwalia, {Manmeet Singh}",
note = "2005 Background: Brain metastases (BM) are common serious complication of NSCLC. Activating mutations in EGFR and ALK constitute 10-15% and 5% of NSCLC respectively. Patients with multiple BM (≥4) have inferior outcomes compared to single or limited BM (≤ 3) in wild type NSCLC.; Journal of Clinical Oncology ; Conference date: 01-01-2020",
year = "2016",
month = may,
day = "20",
doi = "10.1200/JCO.2016.34.15_SUPPL.2005",
language = "American English",
}